ICREA news
“After the end of the world”: next ICREA-CCCB cycle of debates
This November we will be having a new cycle of debates, with significant changes in format and orientation.…
Official statement about the 1st of October 2017
ICREA fully condemns recent violent events, unjustified and unjustifiable, exercised in Catalonia yesterday. We express our rejection, our indignation…
Peptomyc raises 4.2M € to advance its cancer therapy
Laura Soucek (ICREA @ VHIO) and Marie-Eve Beaulieu are the Peptomyc entrepreneurs that last year started the company…
EURAXESS HRS4R Strategy submitted!
After two and a half years of work, we have finally completed the Implementation Phase of the EURAXESS Human…
Clivia Sotomayor, ICREA at ICN2, new Chair of the FET Advisory Group
Clivia will be chairing the Group for the next year. The Future and Emerging Technologies Advisory Group (FETAG) is…
ICREA-FIJC Conference “Across Tumour Heterogeneity and Evolution in Cancer: From in Silico Studies to Clinical Impact”
ICREA Conference Awards are specific, dedicated awards aimed at funding scientific events of the hottest, most advanced topics…
Jornada sobre “Lliçons de les Immunoteràpies del càncer per al tractament del VIH”
L’Institut de Recerca de la Sida IrsiCaixa organitza la jornada “Lliçons de les Immunoteràpies del càncer per al tractament del VIH” dins…
Envellir, una malaltia? ICREA – CCCB Debates
The last cycle of debates by ICREA Research Professors offered four talks on ageing and disease entitled 'Envellir, una…
